Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Urobilinogen, urine; qualitative

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

Urobilinogen is a biochemical compound that results from the reduction of bilirubin, a substance produced during the breakdown of red blood cells. This reduction process primarily occurs in the intestine, where bilirubin is converted into urobilinogen. A small portion of urobilinogen is then reabsorbed from the intestine into the bloodstream and subsequently filtered by the kidneys, which is part of the enterohepatic urobilinogen cycle. The measurement of urobilinogen in urine is significant as it can provide insights into various hepatic and hematological conditions. Elevated levels of urobilinogen in urine may indicate several medical issues, including biliary obstruction, hepatic infections, poisoning, or inflammation, as well as hemolytic anemia. Additionally, elevated levels can occur in cases where there is a large hematoma that the body is in the process of absorbing. Conversely, decreased levels of urobilinogen may be observed in conditions such as congenital enzymatic jaundice or when urine acidifying drugs are present. For qualitative evaluation of urobilinogen, the CPT® code 84578 is utilized, while 84580 is designated for quantitative, timed specimen evaluations, and 84583 is used for semiquantitative evaluations.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

Urobilinogen testing is indicated for the evaluation of various conditions that may affect liver function or red blood cell breakdown. The following are specific indications for performing this test:

  • Biliary Obstruction Elevated urobilinogen levels may suggest a blockage in the bile ducts, which can impede the normal flow of bile and lead to increased bilirubin levels.
  • Hepatic Infection Conditions such as hepatitis or other liver infections can result in altered liver function, leading to changes in urobilinogen levels.
  • Poisoning or Inflammation Exposure to certain toxins or inflammatory processes affecting the liver can disrupt normal bilirubin metabolism, resulting in elevated urobilinogen.
  • Hemolytic Anemia Increased breakdown of red blood cells in hemolytic anemia can lead to higher levels of bilirubin and subsequently urobilinogen in the urine.
  • Large Hematoma Absorption The presence of a significant hematoma that the body is absorbing may also lead to elevated urobilinogen levels as bilirubin is released during the breakdown of red blood cells.
  • Congenital Enzymatic Jaundice Decreased levels of urobilinogen may be observed in patients with congenital enzymatic jaundice, indicating a disruption in bilirubin metabolism.
  • Urine Acidifying Drugs Certain medications that acidify urine can also lead to decreased urobilinogen levels, which may warrant testing to assess liver function.

2. Procedure

The procedure for testing urobilinogen in urine involves the following steps:

  • Sample Collection A urine sample is collected from the patient, typically a midstream sample to ensure accuracy and minimize contamination. Proper collection techniques are essential to obtain a reliable specimen for analysis.
  • Qualitative Testing The collected urine sample is subjected to qualitative testing to determine the presence or absence of urobilinogen. This may involve the use of specific reagents that react with urobilinogen to produce a color change, which can be visually assessed or measured using a spectrophotometer.
  • Result Interpretation The results of the qualitative test are interpreted based on established reference ranges. Elevated or decreased levels of urobilinogen are noted, and any significant findings are documented for further clinical correlation.

3. Post-Procedure

After the urobilinogen testing procedure, the urine sample is typically discarded, and no special post-procedure care is required for the patient. However, it is important for healthcare providers to communicate the results to the patient and discuss any necessary follow-up actions based on the findings. If elevated or decreased levels of urobilinogen are detected, further diagnostic testing or clinical evaluation may be warranted to determine the underlying cause and appropriate management.

Short Descr TEST URINE UROBILINOGEN
Medium Descr ASSAY OF UROBILINOGEN URINE QUALITATIVE
Long Descr Urobilinogen, urine; qualitative
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
Date
Action
Notes
2013-01-01 Changed Medium Descriptor changed.
Pre-1990 Added Code added.
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"